Joseph J Ferra Jr Elevation Oncology, Inc. (ELEV) insider trading activity

Joseph J Ferra Jr is CHIEF EXECUTIVE OFFICER of Elevation Oncology, Inc.. Currently has a direct ownership of 133,205 shares of ELEV, which is worth approximately $34,633. The most recent transaction as insider was on Mar 16, 2025, when has been sold 4,628 shares (Common Stock) at a price of $0.53 per share, resulting in proceeds of $2,452. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 133K

21.67% 3M change

55.47% 12M change

Total Value Held $34,633

Joseph J Ferra Jr Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 16 2025	SELL Payment of exercise price or tax liability	$2,452 $0.53 p/Share	4,628 Reduced 3.36%	133,205 Common Stock
Mar 16 2025	BUY Exercise of conversion of derivative security	-	12,562 Added 8.35%	137,833 Common Stock
Feb 15 2025	SELL Payment of exercise price or tax liability	$6,171 $0.67 p/Share	9,211 Reduced 6.85%	125,271 Common Stock
Feb 15 2025	BUY Exercise of conversion of derivative security	-	25,000 Added 15.68%	134,482 Common Stock
Dec 16 2024	SELL Payment of exercise price or tax liability	$2,962 $0.64 p/Share	4,629 Reduced 4.06%	109,482 Common Stock
Dec 16 2024	BUY Exercise of conversion of derivative security	-	12,563 Added 9.92%	114,111 Common Stock
Sep 16 2024	SELL Payment of exercise price or tax liability	$2,823 $0.61 p/Share	4,628 Reduced 4.36%	101,548 Common Stock
Sep 16 2024	BUY Exercise of conversion of derivative security	-	12,562 Added 10.58%	106,176 Common Stock
Jun 16 2024	SELL Payment of exercise price or tax liability	$14,948 $3.23 p/Share	4,628 Reduced 4.71%	93,614 Common Stock
Jun 16 2024	BUY Exercise of conversion of derivative security	-	12,562 Added 11.34%	98,242 Common Stock
Mar 16 2024	SELL Payment of exercise price or tax liability	$20,953 $4.39 p/Share	4,773 Reduced 5.28%	85,680 Common Stock
Mar 16 2024	BUY Exercise of conversion of derivative security	-	12,562 Added 12.19%	90,453 Common Stock
Dec 16 2023	SELL Payment of exercise price or tax liability	$2,434 $0.51 p/Share	4,773 Reduced 5.77%	77,891 Common Stock
Dec 16 2023	BUY Exercise of conversion of derivative security	-	12,563 Added 13.19%	82,664 Common Stock
Sep 16 2023	SELL Payment of exercise price or tax liability	$3,484 $0.73 p/Share	4,773 Reduced 6.37%	70,101 Common Stock
Sep 16 2023	BUY Exercise of conversion of derivative security	-	12,562 Added 14.37%	74,874 Common Stock
Jun 16 2023	SELL Payment of exercise price or tax liability	$7,016 $1.47 p/Share	4,773 Reduced 7.11%	62,312 Common Stock
Jun 16 2023	BUY Exercise of conversion of derivative security	-	12,563 Added 15.77%	67,085 Common Stock
Mar 16 2023	SELL Payment of exercise price or tax liability	$11,216 $2.35 p/Share	4,773 Reduced 8.05%	54,522 Common Stock
Mar 16 2023	BUY Exercise of conversion of derivative security	-	12,563 Added 17.48%	59,295 Common Stock
Dec 16 2022	SELL Payment of exercise price or tax liability	$4,534 $0.95 p/Share	4,773 Reduced 9.27%	46,732 Common Stock
Dec 16 2022	BUY Exercise of conversion of derivative security	-	12,562 Added 19.61%	51,505 Common Stock
Sep 16 2022	SELL Payment of exercise price or tax liability	$5,966 $1.25 p/Share	4,773 Reduced 10.92%	38,943 Common Stock
Sep 16 2022	BUY Exercise of conversion of derivative security	-	12,562 Added 22.32%	43,716 Common Stock
Jun 16 2022	SELL Payment of exercise price or tax liability	$24,059 $1.26 p/Share	19,095 Reduced 38.0%	31,154 Common Stock

Also insider at

SYRS

Syros Pharmaceuticals, Inc. Healthcare

Chief Financial Officer

JJF

Joseph J Ferra Jr

CHIEF EXECUTIVE OFFICER

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ELEV shares.

Notify only if

Value

Insider Trading

Get notified when an Elevation Oncology, Inc. insider buys or sells ELEV shares.

Notify only if

Operation

Value

Type

News

Receive news related to Elevation Oncology, Inc.

Track Activities on ELEV

Account